Impacto de la implementación de un Software para Dispositivos Móviles como soporte en el manejo terapéutico y de estrategias para el control de infecciones en tres hospitales en Colombia

Datos básicos

Proyecto de investigación externo Internacional UEB-2017-455 Año de incio: 2017 Año de finalización: 2020

Objetivos del proyecto

NA

Documentos

  • No hay documentos

Participantes

Unidades de investigación

Outputs del proyecto


An analysis of the epidemic of klebsiella pneumoniae carbapenemase-producing k. pneumoniae: Convergence of two evolutionary mechanisms creates the "perfect storm"

Rojas L.J.; (...); Arias C.A.

Article. 10.1093/infdis/jix524. 2018

  • Open Access.

Antimicrobial Stewardship programs in Peru: A fundamental agreement

Hernández-Gómez, C; (...); Illescas, LR

Article. 10.4067/S0716-10182019000500565. 2019

  • Open Access.

Carbapenemase-producing Enterobacteriaceae: A diagnostic, epidemiological and therapeutic challenge

Villegas M.V.; (...); Appel T.M.

Article. 10.22354/in.v23i4.808. 2019

  • Open Access.

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia

Ordóñez, K; (...); Villegas, MV

Article. 10.1016/j.bjid.2019.06.010. 2019

  • Open Access.

Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections

Cuesta, DP; (...); Villegas, MV

Article. 10.4067/S0716-10182019000100009. 2019

  • Open Access.

Detection of carbapenemase-producing Pseudomonas aeruginosa: Evaluation of the carbapenem inactivation method (CIM)

Gutiérrez, S; (...); Villegas, MV

Article. 10.1016/j.eimc.2019.02.004. 2019


Distribution and molecular characterization of beta-lactamases in Gram negative bacteria in Colombia (2001-2016)

Rada, AM; (...); Villegas, MV

Review. 10.7705/biomedica.v39i3.4351. 2019

  • Open Access.

Evaluation of Allplex™ Entero-DR assay for detection of antimicrobial resistance determinants from bacterial cultures

Mojica MF; (...); Villegas MV

Article. 10.1186/s13104-020-04997-4. 2020

  • Open Access.

Gram-negative infections: Evolving treatments with expanding options

Villegas M.V., Lyon S.

Conference Paper. 10.4155/fsoa-2018-0071. 2018

  • Open Access.

In vitro susceptibility to ceftazidime/avibactam and comparators in clinical isolates of enterobacterales from five Latin American Countries

Appel TM; (...); Villegas MV

Article. 10.3390/antibiotics9020062. 2020

  • Open Access.

Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa

Mojica MF; (...); Villegas MV

Article. 10.1016/j.jgar.2020.01.003. 2020

  • Open Access.

Citar el proyecto

Compartir el proyecto